FI880744A - Piperazinkarboxylsyra, dess framstaellning och denna innehaollande farmaceutiska produkter. - Google Patents

Piperazinkarboxylsyra, dess framstaellning och denna innehaollande farmaceutiska produkter. Download PDF

Info

Publication number
FI880744A
FI880744A FI880744A FI880744A FI880744A FI 880744 A FI880744 A FI 880744A FI 880744 A FI880744 A FI 880744A FI 880744 A FI880744 A FI 880744A FI 880744 A FI880744 A FI 880744A
Authority
FI
Finland
Prior art keywords
piperazinkarboxylsyra
denna
pharmaceutical product
framstaellning och
dess framstaellning
Prior art date
Application number
FI880744A
Other languages
English (en)
Other versions
FI86733B (fi
FI880744A0 (fi
FI86733C (fi
Inventor
Bernhard Aebischer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI880744A0 publication Critical patent/FI880744A0/fi
Publication of FI880744A publication Critical patent/FI880744A/fi
Publication of FI86733B publication Critical patent/FI86733B/fi
Application granted granted Critical
Publication of FI86733C publication Critical patent/FI86733C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI880744A 1987-02-18 1988-02-17 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar piperazinkarboxylsyra FI86733C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8703749 1987-02-18
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (4)

Publication Number Publication Date
FI880744A0 FI880744A0 (fi) 1988-02-17
FI880744A true FI880744A (fi) 1988-08-19
FI86733B FI86733B (fi) 1992-06-30
FI86733C FI86733C (fi) 1992-10-12

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880744A FI86733C (fi) 1987-02-18 1988-02-17 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar piperazinkarboxylsyra

Country Status (28)

Country Link
JP (1) JPH0723387B2 (fi)
KR (1) KR960015190B1 (fi)
AT (1) AT391320B (fi)
AU (1) AU613009B2 (fi)
BE (1) BE1002427A3 (fi)
CA (1) CA1327799C (fi)
CH (1) CH675125A5 (fi)
CY (1) CY1739A (fi)
DE (1) DE3804936C2 (fi)
DK (1) DK168441B1 (fi)
ES (2) ES2011319A6 (fi)
FI (1) FI86733C (fi)
FR (1) FR2610932B1 (fi)
GB (2) GB8703749D0 (fi)
GR (1) GR1002471B (fi)
HK (1) HK142093A (fi)
HU (2) HU199858B (fi)
IE (1) IE59098B1 (fi)
IL (1) IL85436A0 (fi)
IT (1) IT1219447B (fi)
LU (1) LU87129A1 (fi)
MY (1) MY103206A (fi)
NL (1) NL8800412A (fi)
NZ (1) NZ223529A (fi)
PH (1) PH25512A (fi)
PT (1) PT86776B (fi)
SE (1) SE467256B (fi)
ZA (1) ZA881146B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
US6214604B1 (en) * 1995-05-08 2001-04-10 Lonza Ag Biotechnical production process of piperazine R-α-carboxylic acids and piperazine S-α-carboxylic acid amide
EA001904B1 (ru) 1997-05-12 2001-10-22 ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. Арилзамещенные пиперазины для лечения доброкачественной гиперплазии простаты
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Also Published As

Publication number Publication date
JPH0723387B2 (ja) 1995-03-15
FI86733B (fi) 1992-06-30
ATA36788A (de) 1990-03-15
GR1002471B (el) 1996-11-15
SE8800541A (fi) 1988-08-19
NL8800412A (nl) 1988-09-16
AU1175888A (en) 1988-08-25
DK79688A (da) 1988-08-19
IT8847631A0 (it) 1988-02-12
BE1002427A3 (fr) 1991-02-05
IE880413L (en) 1988-08-18
HK142093A (en) 1994-01-07
HUT49361A (en) 1989-09-28
HU199858B (en) 1990-03-28
NZ223529A (en) 1991-02-26
DK79688D0 (da) 1988-02-16
GR880100084A (el) 1988-12-16
FR2610932B1 (fr) 1990-11-16
IT1219447B (it) 1990-05-18
ES2021904A6 (es) 1991-11-16
AT391320B (de) 1990-09-25
PH25512A (en) 1991-07-24
SE467256B (sv) 1992-06-22
MY103206A (en) 1993-05-29
ZA881146B (en) 1989-10-25
GB2201676B (en) 1991-01-02
IL85436A (fi) 1992-12-01
PT86776B (pt) 1992-05-29
KR960015190B1 (ko) 1996-11-01
GB8803438D0 (en) 1988-03-16
FI880744A0 (fi) 1988-02-17
DE3804936A1 (de) 1988-09-01
CY1739A (en) 1995-10-20
IL85436A0 (en) 1988-07-31
PT86776A (pt) 1988-03-01
DK168441B1 (da) 1994-03-28
JPS63203691A (ja) 1988-08-23
DE3804936C2 (de) 1997-02-13
ES2011319A6 (es) 1990-01-01
LU87129A1 (fr) 1988-09-20
FI86733C (fi) 1992-10-12
SE8800541D0 (sv) 1988-02-17
AU613009B2 (en) 1991-07-25
FR2610932A1 (fr) 1988-08-19
CA1327799C (en) 1994-03-15
HU211269A9 (en) 1995-11-28
IE59098B1 (en) 1994-01-12
GB8703749D0 (en) 1987-03-25
GB2201676A (en) 1988-09-07
CH675125A5 (fi) 1990-08-31
KR880009944A (ko) 1988-10-06

Similar Documents

Publication Publication Date Title
FI842395A (fi) 13 -alkylgonaner, deras framstaellning och dessa innehaollande farmaceutiska produkter.
DE69018647D1 (de) Arzneimittel.
FI872114A (fi) Foerfarande foer tryckning av formade produkter haerledda fraon aramidfibrer.
FI893340A (fi) Foerfarande foer att erhaolla farmaceutiska sammansaettningar foer att hindra smittbara koenssjukdomar.
FI880195A (fi) Terapeutiska produkter.
FI894998A0 (fi) Cellodlingsprocesser, material och produkter.
FI900035A (fi) Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI850455L (fi) Farmaceutiska produkter.
FI862590A0 (fi) Farmaceutiska produkter.
FI880744A (fi) Piperazinkarboxylsyra, dess framstaellning och denna innehaollande farmaceutiska produkter.
FI863382A0 (fi) Substituerade toluidiner, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning foer haemmande av magsyrasekret.
DE3763519D1 (de) Heilnahrungsmittel.
FI901938A0 (fi) Silversulfadiazin innehaollande farmaceutiska produkter foer lokalt externt bruk.
FI883443A (fi) Foerfarande och anordning foer att aotskilja i fjaellformation inkommande produkter, isynnerhet trycksaker.
FI863470A (fi) 6-fenoximetyl-4 -hydroxitetrahydropyran-2-oner, foerfarande foer deras framstaellning, deras anvaendning som laekemedel farmaceutiska produkter och mellanprodukter.
FI844153A0 (fi) 1,2-ditiolanderivat, deras framstaellningsfoerfarande, dessa innehaollande farmaceutiska produkter och deras anvaendning.
FI905493A0 (fi) Nya pyridinderivat, dessa innehaollande farmaceutiska produkter och foerfarande foer deras framstaellning.
DE3781045D1 (de) Antirheumatisches arzneimittel.
FI885873A0 (fi) Loeslig rekombinant-fc -reseptor, dess framstaellning och anvaendning.
FI883320A (fi) --laktam, dess framstaellning och mellanprodukter foer dess framstaellning.
FI900312A0 (fi) Nya benzopyranderivat, deras framstaellning och dess innehaollande farmaceutiska produkter.
FI830399L (fi) Mjoeldryge-alkaloider, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
FI883008A0 (fi) 8 -acylaminoergolin, dess framstaellning och farmaceutiska kompositioner innehaollande detsamma.
FI822980A0 (fi) Furanokromonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
DE3887237D1 (de) Arzneimittel.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG